The trajectory of Viagra, initially marketed by copyright, presents a intricate case study for investors considering the pharmaceutical sector. While its groundbreaking success and creation of countless in sales, the intellectual property end has opened the floodgates for alternative medications, substantially eroding earnings prospects . This shif